Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
RMD Open|November 11, 2025
Haematological malignancies in systemic sclerosis: a population-based nationwide register studyKarin Gunnarsson, Luigi Annicchiarico, Anna Ravn Landtblom, et al.
European Journal of Haematology|December 22, 2019
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-upErik Ahlstrand, Jan Samuelsson, Marie Lindgren, et al.
British Journal of Haematology|June 3, 2025
Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register-based matched cohort studyNurgul Batyrbekova, Malin Hultcrantz, Anna Ravn Landtblom, et al.
Haematologica|September 25, 2025
Loss of life expectancy in patients with myeloproliferative neoplasms in SwedenYuliya Leontyeva, Anna Ravn Landtblom, Malin Hultcrantz, et al.
Leukemia|March 9, 2024
Childbirth rates in women with myeloproliferative neoplasmsAnna Ravn Landtblom, Therese M-L Andersson, Anna L V Johansson, et al.
European Journal of Haematology|June 13, 2022
Survival and risk of vascular complications in myelofibrosis-A population-based study from the Swedish MPN groupMarie Lindgren, Björn Andréasson, Jan Samuelsson, et al.
Leukemia|March 15, 2018
Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patientsAnna Ravn Landtblom, Hannah Bower, Therese M-L Andersson, et al.
BMC Medical Research Methodology|November 10, 2022
Modelling multiple time-scales with flexible parametric survival modelsNurgul Batyrbekova, Hannah Bower, Paul W Dickman, et al.
Leukemia|June 18, 2020
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patientsAnna Ravn Landtblom, Therese M-L Andersson, Paul W Dickman, et al.
Pageof 2